For individuals with opioid use disorder undergoing a buprenorphine/naloxone taper, suvorexant might be a promising treatment for reducing sleep disturbance and easing opioid withdrawal, according to a study published online ...
Jul 12, 2022
0
30
Injections of hyaluronic acid (known as viscosupplementation) to treat knee osteoarthritis make almost no difference to pain and might raise risk of adverse events, suggests research published by The BMJ today.
Jul 7, 2022
0
77
An experimental drug used to fight cancer may reduce the risk of death for COVID-19 patients by roughly 55%, a new study suggests.
Jul 6, 2022
0
11
Pregnancy chances in IVF can be affected by many factors including the type of bacteria which naturally colonize the reproductive tract. 'Good' bacteria in the form of probiotics are of increasing interest in treating women ...
Jul 4, 2022
0
4
For healthy adults, the bivalent prefusion F respiratory syncytial virus (RSVpreF) vaccine is effective against symptomatic RSV infection and viral shedding, according to a study published in the June 23 issue of the New ...
Jun 23, 2022
0
17
Skyrizi (risankizumab-rzaa), an interleukin-23 inhibitor, has received U.S. Food and Drug Administration approval to treat moderately to severely active Crohn disease (CD) in adults, according to AbbVie.
Jun 20, 2022
0
4
The Food and Drug Administration on Monday approved a drug called baricitinib as the first oral tablet for treating severe alopecia areata, an autoimmune disorder affecting more than 300,000 people in the United States every ...
Jun 14, 2022
0
8
For individuals who receive two doses of mRNA-1273 severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine, vaccine efficacy (VE) against symptomatic COVID-19 appears to peak at 120 days after the first dose, ...
Jun 13, 2022
0
19
For youth with type 2 diabetes, dulaglutide is superior to placebo for reducing mean glycated hemoglobin level, according to a study published online June 4 in the New England Journal of Medicine to coincide with the annual ...
Jun 8, 2022
0
2
A panel of experts convened by the US drug regulator was meeting Tuesday to consider authorizing the Novavax COVID-19 shot, a late runner in the fight against the virus that could nonetheless play a role in overcoming vaccine ...
Jun 7, 2022
0
2
